ENTRY       D00413                      Drug
NAME        Zidovudine (JP18/USP/INN);
            Azidothymidine;
            Retrovir (TN)
  ABBR      AZT, ZDV
PRODUCT     RETROVIR (ViiV Healthcare Company)
  GENERIC   ZIDOVUDINE (Aurobindo Pharma Limited)
            ZIDOVUDINE (Aurobindo Pharma Limited)
            ZIDOVUDINE (Aurobindo Pharma Limited)
            ZIDOVUDINE (Camber Pharmaceuticals)
            ZIDOVUDINE (REMEDYREPACK)
FORMULA     C10H13N5O4
EXACT_MASS  267.0968
MOL_WEIGHT  267.2413
CLASS       Antiviral
             DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
             DG03107  Anti-HIV agent
              DG01656  HIV reverse transcriptase inhibitor
            Transporter substrate
             DG02859  SLC22A6 substrate
             DG02860  SLC22A8 substrate
REMARK      Same as: C07210
            Therapeutic category: 6250
            ATC code: J05AF01
            Product: D00413<JP/US>
            Product (mixture): D07507<JP/US> D10838<US>
EFFICACY    Antiviral, Reverse transcriptase inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
METABOLISM  Transporter: SLC22A6 [HSA:9356], SLC22A8 [HSA:9376]
INTERACTION  
STR_MAP     map07044  Antiviral agents
            map07053  Anti-HIV agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
                 J05AF01 Zidovudine
                  D00413  Zidovudine (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
               Zidovudine
                D00413  Zidovudine (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D00413  Zidovudine (JP18/USP/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               D00413  Zidovudine
              DG03107  Anti-HIV agent
               DG01656  HIV reverse transcriptase inhibitor
                D00413  Zidovudine
             Transporter substrate
              DG02859  SLC22A6 substrate
               D00413  Zidovudine
              DG02860  SLC22A8 substrate
               D00413  Zidovudine
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D00413  Zidovudine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D00413  Zidovudine (JP18/USP/INN) &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D00413  Zidovudine (JP18/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00413  Zidovudine
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D00413
DBLINKS     CAS: 30516-87-1
            PubChem: 7847479
            ChEBI: 10110
            PDB-CCD: AZZ
            LigandBox: D00413
            NIKKAJI: J20.566D
ATOM        19
            1   C1y C    18.8657  -16.2961
            2   N4y N    20.5359  -15.5648
            3   C1x C    18.4295  -17.5962
            4   O2x O    17.7601  -15.4854
            5   C8y C    21.6329  -16.2525
            6   C8x C    20.4803  -14.1952
            7   C1y C    17.0654  -17.5917
            8   C1y C    16.6491  -16.2888
            9   N4x N    22.8245  -15.5863
            10  O5x O    21.6194  -17.6179
            11  C8y C    21.6659  -13.5204
            12  N2b N    16.2659  -18.6975
            13  C1b C    15.3431  -15.8696
            14  C8y C    22.8512  -14.2198
            15  C1a C    21.6815  -12.1564
            16  O1a O    14.3229  -16.7755
            17  O5x O    24.0708  -13.6122
            18  N0  N    15.3644  -19.7657 #+
            19  N2a N    14.3822  -20.9233 #-
BOND        20
            1     1   2 1 #Up
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 2
            10    6  11 2
            11    7  12 1 #Down
            12    8  13 1 #Up
            13    9  14 1
            14   11  15 1
            15   13  16 1
            16   14  17 2
            17    7   8 1
            18   11  14 1
            19   12  18 2
            20   18  19 2
///
